Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Effects of
n-octane
and n-nonane (1 ml per kg body weight daily) on hepatic and serum enzymes, which reflect abnormal liver function and concentration of lipid and nucleic acid (serum and liver), were studied after 2 and 7 days intraperitoneal administration to albino rats. Decreased activities of serum acetylcholine esterase and carboxyl esterase were observed, together with an increase in FDP
aldolase
activity. Significant decrease in the concentration of albumin, total protein, and total and esterified cholesterol in serum have been noted after
n-octane
and n-nonane administration for 7 days. Also, free cholesterol content of liver was elevated significantly after solvents exposure.
...
PMID:Hepatotoxicity in albino rats exposed to n-octane and n-nonane. 258 19